GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Debt-to-Revenue

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Debt-to-Revenue : 0.27 (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Cryofocus Medtech (Shanghai) Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$3.02 Mil. Cryofocus Medtech (Shanghai) Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was HK$7.95 Mil. Cryofocus Medtech (Shanghai) Co's annualized Revenue for the quarter that ended in Jun. 2023 was HK$41.38 Mil. Cryofocus Medtech (Shanghai) Co's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 was 0.27.

Cryofocus Medtech (Shanghai) Co Debt-to-Revenue Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co Debt-to-Revenue Chart

Cryofocus Medtech (Shanghai) Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Debt-to-Revenue
0.06 0.40 0.42 0.27

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial N/A - 0.34 0.27 0.25

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's Debt-to-Revenue

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryofocus Medtech (Shanghai) Co's Debt-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's Debt-to-Revenue falls into.


Cryofocus Medtech (Shanghai) Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Cryofocus Medtech (Shanghai) Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.833 + 8.866) / 30.318
=0.42

Cryofocus Medtech (Shanghai) Co's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(3.022 + 7.952) / 41.376
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Jun. 2023) Revenue data.

Cryofocus Medtech (Shanghai) Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » Debt-to-Revenue
Comparable Companies
HKSE:02160 HKSE:01763 HKSE:09996 HKSE:06669 HKSE:02190 HKSE:02407 HKSE:01696 HKSE:02500 HKSE:02235 HKSE:02172 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
Building 15, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 200120
Website
https://www.cryofocus.com
Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Headlines

No Headlines